➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
AstraZeneca
Dow
McKinsey

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. TWI PHARMACEUTICALS, INC. (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. TWI PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SUPERNUS PHARMACEUTICALS, INC. v. TWI PHARMACEUTICALS, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 361 infringe U.S. Patent Nos. 7,722,898 (the “’898 Patent”), 7,910,131 (the “’131 Patent”), and 8,821,930… ’898 Patent, the ’131 Patent, and the ’930 Patent [Docket No. 197]. 2 Although the Patents-in-Suit…8,821,930 (the “’930 Patent”) (collectively, the “Supernus Patents” or the “Patents-in-Suit”).1 Supernus…4 ’898 Patent, Claims 1, 11, and 21 of the ’131 Patent, and Claims 1 and 19 of the ’930 Patent. The… of Supernus as to the ’898 Patent, the ’131 Patent, and the ’930 Patent. This Opinion constitutes External link to document
0000-00-00 402 Opinion United States Patent Nos. 7,722,898 (“the ’898 patent”); 7,910,131 (“the ’131 patent”); 8,617,600 (“…(“the ’600 patent”); and 8,821,930 (“the ’930 patent”). Supernus alleged that Defendants’ filing of an… expiration of Supernus’ patents constituted infringement of those patents. Defendants answered with…and ‘930 patents, setting aside Plaintiff’s third count of infringement of the ‘600 patent. [Dkt. Entry…involving three of the same patents-in-suit, i.e., the ‘898, ‘131 and ‘600 patents. Claim construction of External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
McKinsey
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.